Background Case-mix adjustment is an established method to take account of variations across cohorts in baseline patient factors, when comparing health outcomes. Although commonplace, there is a lack of evidence as to the most appropriate case-mix adjustment model to use to enable fair comparisons of PROM data in musculoskeletal services. Objectives To conduct a systematic review summarising evidence of the development, validation, and performance of musculoskeletal case-mix adjustment models, and to make recommendations for future methods. Data Sources Searches included; AMED, CINAHL, EMBASE, HMIC, MEDLINE, and grey literature. Eligibility Criteria Studies; from January 1992-May 2017, English language, musculoskeletal adult population, developing or validating a case-mix adjustment model, using a relevant PROM, and using patient factors feasible for clinical collection. Data Synthesis Two reviewers evaluated selected papers. The CASP Cohort Tool was used to assess quality. Results Fourteen studies were included; eight US studies on the Focus on Therapeutic Outcomes model (pooled n = 546,726 patients (with pre/post treatment data)) and six UK studies related to the UK National PROMs Programme model (pooled n = 282,424 patients (with pre/post treatment data)). The majority used retrospective data, restricted to complete datasets. Both US and UK models showed good predictive ability (R2 18-42%). Common model variables were; baseline PROM score, age, sex, comorbidities, symptom duration, and surgical history. Reduced quality scores were mainly due to acceptability of patient recruitment, and completeness and length of patient follow up. Conclusion Significant methodological crossover was found. Further studies are however needed to externally validate and develop models across musculoskeletal settings.
Introduction
Routine use of patient reported outcome measures (PROMs) can help patients and clinicians make better decisions, and enable comparisons of providers' performance facilitating quality improvement [1] . For example, the UK example to enable fair comparisons across different musculoskeletal physiotherapy services it may be appropriate to adjust for population differences in age or symptom duration, as these are known to influence patient outcomes following treatment [5] . Other known patient factors that influence musculoskeletal treatment outcomes include; gender, symptom severity, and impairment type [6] . These patient factors are beyond the control of the treatment provider, unlike provider factors such as the waiting time, clinic setting, or treating clinician, which also influence treatment outcomes [7] . Case-mix adjustment aims to avoid inclusion of provider variables as these variables could remove effects that may be attributable to local quality improvement initiatives, and potentially can adjust out the differences in quality and performance that are being investigated [8] . For example, if one physiotherapy service had treating clinicians of a much higher grade than another, and grade of therapist was adjusted for when examining their respective treatment outcomes, then any variation due to the differing skill-mix between the services would be adjusted out rather than being used to help explain the differences and inform quality improvement initiatives. Most case-mix models therefore only adjust for patient factors to allow for fair inter provider comparisons [8] .
Within a musculoskeletal context the evidence for casemix adjustment models to compare inter provider treatment outcomes has not been systematically evaluated, and there has been no previous review of the literature to the authors' knowledge. This review therefore aims to summarise the evidence for the development, validation, and performance of musculoskeletal case-mix adjustment models, and make recommendations for future case-mix adjustment methodology.
Methods
This review followed protocol guidance set out within the PRISMA statement [9] , and has been registered on the PROSPERO database (CRD42017055948).
Eligibility Criteria
Inclusion criteria were: studies from January 1992 to May 2017 (in line with early implementers of musculoskeletal PROM collection [10] and to provide currency and applicability of results), English language studies (due to resource limits), observational cohort studies, adult patients seeking treatment for musculoskeletal conditions, use of a case-mix adjustment model (focus on development, refinement or validation), self-reported treatment outcomes at a follow-up time-point (capturing treatment effect/change), and models adjusting PROMs and including variables feasible for widespread collection (not using variables such as imaging results that are not uniformly collected). Exclusions were: studies not reporting detailed results, and those not reporting statistical model effectiveness.
Searches
A search strategy was developed iteratively with guidance from an experienced systematic reviewer, initially conducting test searches for a single database until the refined strategy was agreed that amalgamated sets of search terms, reduced individual terms, and exploded terms such as 'musculoskeletal' to optimise the balance between search sensitivity and precision [11] . Search-terms included key words for; target population; musculoskeletal conditions; outcomes; and methodology. Electronic databases searched were: CINAHL; MEDLINE; EMBASE; AMED and HMIC (see Appendix A for search strategy (MEDLINE)) from January 1992 to May 2017. Grey literature included searches of NHS Evidence websites of the Department of Health [12] and NICE [13] . Additional searches included references and citations of included studies. Seminal authors/research groups were also contacted for all identified case-mix models to ensure latest iterations were included and to identify any additional models.
Selection Process
One independent reviewer (RB) undertook a preliminary screen of all titles to remove studies clearly and unquestionably excluded from the study. RB then screened all remaining abstracts identified from searches alongside a second reviewer (AB or JH). Two independent reviewers (RB and JH or AB or ML) then read full articles identified to confirm they met the inclusion criteria.
Data Extraction and Quality Assessment
Information on identified articles was independently entered onto a data extraction form by the two reviewers, with the form reflecting the key themes from the STROBE Checklist [14] , and quality assessed using the CASP Cohort Quality Tool [15] . Agreement on study inclusion was first discussed between two reviewers. As there were no disputed studies discussion for agreement between all reviewers was not required.
Data synthesis
A systematic narrative synthesis was conducted, with information presented in table and text format to summarise and explain the history and development of identified casemix adjustment models, and the overall study findings. A meta-analysis pooling the study data was not possible due to the large methodological diversity (heterogeneity) among studies [11] in patient factors and statistical methods used. For this reason, results were summarised in tables and discussed in detail. Each case-mix adjustment model and their associated studies/papers and statistical methods were presented together for ease of viewing overarching findings. 
Results

Search Results
Electronic database searches identified 755 articles for consideration with 517 remaining after duplicate removal (see Fig. 1 ). Grey literature and additional searching identified a further 12 articles. All seven experts (or alternative experts from their research group) responded and this identified one additional manuscript that was being prepared for submission that was unable to be included within the review. Following screening, fourteen articles were included (see Fig. 1 ). Two broad case-mix adjustment models were identified; US Focus on Therapeutic Outcomes (FOTO), and UK National PROMs (NPROMs).
Eight of the fourteen studies included were undertaken in the US, using data from the FOTO database [5, 6, [16] [17] [18] [19] , with four of those authored (primary author) by members of the FOTO Research Advisory Board (FRAB) [5, 6, 17, 20] . The other four were independently led and given access to the FOTO database [16, 18, 19, 21] although two of them were also co-authored by FRAB members [16, 18] . Included study sample sizes ranged from n = 323 [17] to n = 189,088 [5] .
The pooled sample size across US studies with pre and post treatment data was 546,726.
Six of the fourteen included studies were UK based. These included feasibility work for the NHS England NPROMs Programme [22] , NPROMs publications [8, 23, 24] , and independent researchers using NPROMs data [25, 26] . All of these studies were only identified following review of the grey literature/additional searches as they were all NHS publications or secondary analyses of NHS data. Included study sample sizes ranged from n = 387 [22] to NPROMs data which increased yearly from; 2009-10 (n = 85,177), 2010-11 (n = 95,406), 2011-12 (n = 101,454) totalling 282,037 patients [23, 24] . The pooled sample size across UK studies with pre and post treatment data was 282,424.
Follow up was standardised at six months across UK studies but was non-standardised in US FOTO studies with collection at the end of the treatment episode. All included studies were cohort studies, with three prospectively collecting data [8, 18, 22] , and the rest undertaking retrospective analyses of existing datasets. For results detail see Table 1 for quality of included studies, Table 2 for summary of articles included, and Table 3 for summary of model variables within included studies.
Quality Appraisal
The CASP quality evaluation found that studies were of a good quality (see Table 1 ). There were however consistent sources of bias across studies within identified areas such as patient recruitment and completeness of follow up, which are discussed below.
Key sources of bias across US studies included: Selectionbias due to the exclusion of a large percentage of participants with missing data (see Table 1 ). Hart et al. [17] for example were only able to include 323 of 39,529 patients (0.8%) within their routine dataset as only these patients had data for all psychosocial measures pertinent to the study, as collecting multiple psychological measures was not routine practice. This, however, may have biased their sample to those more likely to be psychologically impaired (as acknowledged by the authors). Three of the eight US studies did however use inverse probability weighting to account for missing data [18, 19, 21] . Four studies compared baseline characteristics between those with missing and complete data to assess likelihood of bias, broadly concluding that although some differences were found these were unlikely to lead to systematic selection biases as missing data included both patients with characteristics associated with better and worse outcome [5, 6, 17, 20] . Patients were however also limited to those attending clinics using FOTO software so may not be representative of clinics across the US (n = 4776 clinics currently across the US [10] ). All US studies had non-standardised follow-up outcome assessment time-points with collection at the completion of the individual's treatment episode, both preventing the collection of follow up data for those who ceased attending for treatment and limiting the ability to
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Model development history US Model
Early FOTO models made case-mix adjustments using 12 baseline variables as demonstrated by Hart and Connolly [6] (see Table 3 ) that were found to have a significant effect on discharge functional status (FS). This model predicted 35% of total variance, meaning that 35% of the variance in post treatment outcome could be explained by the model. The three most important patient factors in their model were; baseline FS, age and symptom duration [6] , supporting work from Resnik and Hart [16] . FOTO Inc. later moved to a casemix adjustment model with eight patient factors, aware of the need to balance model performance with data collection feasibility [6] , as demonstrated in the paper by Hart et al. [5] , who looked at the benefit of adding fear avoidance beliefs (FABQ-PA) to the model. Their results demonstrated R2 values of 0.2997 and 0.3010 respectively, with and without the inclusion of the FABQ-PA, thus improving model predictive ability but only slightly, and therefore not recommending this variable for model inclusion.
UK Model
In 2007 Browne et al. [22] , set out to determine the feasibility of collecting pre and post-operative outcome data from patients undergoing elective surgery, and to develop methods to analyse and present the pooled data from different hospitals. Elective surgeries included five areas, with two of musculoskeletal interest: unilateral hip replacement and unilateral knee replacement. Significant variables within their case-mix adjustment models were baseline PROM score, comorbidities, general health, surgical history, age, and Index of Multiple Deprivation (IMD). Models explained between 24% and 27% of total variance in treatment outcome.
Following the feasibility work by Browne et al. [22] , Coles [8] published the full UK NPROMs case-mix adjustment methodology (see Table 3 for list of variables). Coles [8] describes six orthopaedic models (separate models for each PROM used and for each intervention). Models ranged from 16-20 included variables and explained between 23% and 30% of total variance. All models found the patient's baseline score to be highly predictive of outcome, as well as IMD, comorbidities, patients reporting themselves free of a disability (positive impact), and general health.
In 2011 increased data was available from the NPROMs collection which aided further model refinement, including changing the variables relating to co-morbidities and then removing general health [23] . Key predictive variables within the updated model were baseline PROM score, disability status, comorbidity of depression, patient needing assistance with questionnaire, and IMD [23] . In 2013, an alternative aggregation model (AAM) was proposed by NHS England [31] , to further improve model stability. The full model was also updated following the separation out of primary and revision surgery (giving less prediction error). Significant model changes included removing the previous surgery variable and inclusion of some additional patient diagnostic codes. Key variables predicting outcome across updated primary hip and knee models were; baseline PROM score, age, sex, assistance with questionnaire, disability status, comorbidities, ethnicity, diagnostic codes, and IMD [24] .
Model validation US Model
Hart and Connolly [6] used two methods to validate the FOTO case-mix adjustment model. The patient sample was split into two, one to develop the model and one to test the stability of independent variables. 95% confidence intervals for the beta coefficients for all case-mix adjustment variables were similar. In the development sample the predicted discharge FS was very close to the actual discharge FS (average predictive ratio 1.045), although the model slightly over predicted FS in the second testing sample. The paper by Hart et al. [5] also carried out a split-half validation method to create a developmental and testing sample. No differences were found between beta coefficients between developmental and testing samples (p < 0.05), again suggesting stability within the predictive model [5] .
UK Model
The inception NPROMs paper [8] considered the face validity of the case-mix adjustment models, appropriateness of scale, and direction and stability of the coefficients. The developed model was then tested in a subset of data. Comparisons between datasets and early testing suggested scope for removal of further variables either due to low incidence or volatility. The model for Knee surgery using EQ5D VAS as the outcome showed the only significant difference in samples. This was due to the low incidence of some comorbidities, and lack of specific admission and discharge data. All models showed face validity containing appropriate variables with directionally expected coefficients. Nuttall et al. [26] independently reviewed case-mix adjustment of NPROMs data. Mean predicted post-operative scores and mean actual scores were compared using three statistical methods (ordinary least squares (OLS), fixed effects (FE), and random [26] .
Model statistical methods
The majority of studies used a stepwise approach when building a new regression model in order to make the most parsimonious model for clinical practice, and used specific significance levels (0.05 [6] , 0.1 [20] and 0.15 [8] ) for inclusion/exclusion of independent explanatory variables. Early US and UK models used an ordinary least squares (OLS) multivariate regression method to estimate model power (R2) [6, 8] . Hierarchical models were demonstrated in later papers [19, 21, 27] . UK NPROMs moved to the use of a generalised least squares (GLS) method in 2011 [23] . Support is growing for the use of GLS [23, 26] and hierarchical mixed models [19] that take into account the nature and distribution of the data, including random clinic effects such as clustering (unmeasured factors within clinics that may affect outcome). The majority of latter papers therefore include using a stepwise approach to model development, and a GLS or hierarchical model for statistical analysis.
Model predictive abilities
Using regression analysis, goodness of fit can be found by calculating R2 which is usually expressed as a percentage. It explains the percentage of the variation in the dependent variable (PROM score) that can be explained by its relationship with the independent variables (patient factors) [32] . Predictive ability across US study models ranged from 18-42% [5, 6, 16, 17, 18, 19, 20] and in UK models from 23-30% [8, 22, 26] , demonstrating moderate to strong predictive ability across models [33] . Table 3 details the patient factor variables used most commonly (those used in 3 or more studies) in included case-mix adjustment models. It can be seen that the most widely used variables across models predicting outcome include: baseline PROM score, comorbidities, surgical history, IMD, age, payer, symptom duration, impairment type, assistance with questionnaire, self-reported disability, gender, and ethnicity. All of these variables are feasible for widespread clinical collection and warrant being considered for inclusion in future musculoskeletal case-mix adjustment modelling. Variables such as exercise history, living alone, FABQ, use of medication, and pain intensity had some limited support but require further investigation before their inclusion can be fully justified. All US studies used the payer variable and all UK studies used the IMD, these two variables may measure a similar construct as payer types have been used as proxy measures for a variety of demographic factors [19, 34] .
Discussion
Although there is considerable crossover in variables included within models, there is wide disparity in how variables are collated and entered into regression models, with a mixture of continuous, categorical and binary data. Models also used different outcome tools and different timing of follow-up data collection. This would need to be considered when looking to test, replicate or build upon existing case-mix adjustment models, as when and how predictors and treatment outcomes are measured can have significant effects on model predictive performance [28] .
Limitations of the review
The review focussed on the case-mix adjustment of musculoskeletal PROM data. However, the outcome used within studies was not limited and therefore studies and the predictive performance of models identified cannot be fully compared. Evidence from the UK NPROMs research demonstrates that different variables are necessary dependent on the outcome used [8, 24] . The review also included all healthcare settings including primary, community and secondary care. The limitation of this breadth is again the comparability of included studies, as patients, treatments and outcomes across settings all vary significantly. The review was also limited to English language publications meaning that there may be models reported in languages other than English that have not been included.
Summary of findings
Two broad case-mix adjustment models have been identified within the review. Neither model however has been externally validated. The two models are distinct in that one model is currently used within a community setting in the US (FOTO), and the other in a UK secondary care surgical setting (NPROMs). Future research is needed to externally validate these existing models within and across musculoskeletal settings and countries, in order to be able to implement these models across healthcare settings.
Recommendations for future case-mix adjustment modelling of musculoskeletal PROMs based on the combined study findings are:
1. Patient factor variables warranting strong consideration for inclusion are: baseline PROM score, age, gender, comorbidities, symptom duration, surgical history, payer, impairment type, IMD, ethnicity, assistance with questionnaire, and self-reported disability. 2. A stepwise approach to model development is recommended, with significance levels of 0.05-0.15 demonstrated within included studies [6, 8, 20 ]. 3. Statistical methods for consideration include GLS and hierarchical modelling which may be preferential to an OLS method due to accounting for clustering. 4. Methods need to minimise or account for missing data using structured prospective data collection and statistical methods such as data imputation or inverse probability weighting.
5. Defined PROM data capture at the start and end of treatment with a standardised follow up time-point is recommended to reduce risk of bias.
Conclusion
Results demonstrate that there is strong evidence to support the use of case-mix adjustment modelling in musculoskeletal practice, and results highlight common areas of overlap between US and UK models, and models used within a community and secondary care setting. These results have been summarised to aid development of case-mix adjustment methodology alongside much needed external validation of existing models, with the aim of optimising case-mix adjustment of musculoskeletal health outcomes. This will allow for effective performance profiling and future benchmarking of musculoskeletal services, both nationally and internationally.
Contribution of the Paper
• This systematic review has identified two broad musculoskeletal case-mix adjustment models, and highlights both the commonalities in case-mix adjustment approaches but also the need for further good quality studies to inform future practice.
• Effective case-mix adjustment modelling across musculoskeletal clinical pathways of care will allow for further development of performance profiling and benchmarking across musculoskeletal practice, with the aim of improving quality and equity of musculoskeletal healthcare provision.
